Corporate Action23 Oct 2026, 06:30 pm
Sudarshan Pharma Shares to List on NSE Main Board Oct 27
AI Summary
Sudarshan Pharma Industries Ltd announced that its equity shares will be listed and admitted for trading on the Capital Market Segment (Main Board) of the National Stock Exchange of India Limited (NSE) effective October 27, 2026. This migration follows the company's transition from the SME Platform of the Bombay Stock Exchange (BSE). The NSE has confirmed the listing, with 254,470,600 equity shares of Re. 1 each to be traded under the symbol SUDARSHAN and series EQ. The company will utilize the NSE Electronic Application Processing System (NEAPS) for all future filings.
Key Highlights
- Sudarshan Pharma's shares migrate from BSE SME to NSE Main Board.
- Listing on NSE Capital Market Segment effective October 27, 2026.
- 254,470,600 equity shares to be listed under symbol SUDARSHAN.
- Company to use NEAPS for all future regulatory filings.
- Migration signifies increased market access and visibility.
Price Impact
More from SUDARSHAN